Current trends in the development of anticoagulant and antithrombotic drugs
- 1 May 1994
- journal article
- Published by Elsevier in Medical Clinics of North America
- Vol. 78 (3) , 713-731
- https://doi.org/10.1016/s0025-7125(16)30154-7
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Acute pulmonary edema associated with use of low-molecular weight dextran for prevention of microvascular thrombosisThe Journal of Hand Surgery, 1990
- Pharmacotherapeutic Aspects of Unfractionated and Low Molecular Weight HeparinsDrugs, 1990
- Low Molecular Weight Heparins and BleedingSeminars in Thrombosis and Hemostasis, 1989
- Chemical and Biological Heterogeneity in Low Molecular Weight Heparins: Implications for Clinical Use and StandardizationSeminars in Thrombosis and Hemostasis, 1989
- Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgeryBritish Journal of Surgery, 1988
- Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosisBritish Journal of Surgery, 1988
- Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous HeparinNew England Journal of Medicine, 1988
- Development of Heparin Fractions: Some Overlooked ConsiderationsSeminars in Thrombosis and Hemostasis, 1985
- Heparin, Its Fractions, Fragments and Derivatives Some Newer PerspectivesSeminars in Thrombosis and Hemostasis, 1985
- Adjusted versus Fixed-Dose Subcutaneous Heparin in the Prevention of Deep-Vein Thrombosis after Total Hip ReplacementNew England Journal of Medicine, 1983